NCT06390696Recruiting
Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
Biodiversity Interventions for Well-being - the Effect of Biodiversity Exposure on Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 30 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The prevalence of atopic dermatitis has increased along with urbanization and biodiversity loss. According to biodiversity hypothesis, the main reason is urban lifestyle and reduced contact to microbial diversity. Previous studies indicate association between atopic dermatitis and exposure to natural microbes in childhood. Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis will investigate whether the exposure to microbial diversity in sandbox reduces the symptoms of atopic dermatitis, alters commensal microbiota and modifies immune regulation in children.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 25 Apr 2024
- Start date
- 26 May 2023
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Natural Resources Institute Finland
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06390696
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 26 May 2023 to the primary completion date, 30 Sept 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Immune deficiencies, i.e., antibody deficiency
- Immunosuppressive systematic medications
- Topical medication for the treatment of atopic dermatitis during the trial
- Non-participation in the national vaccine program
Other illness
- A disease affecting immune response (e.g., colitis ulcerosa, rheumatoid arthritis, Crohn's disease, diabetes)
- Cancer diagnosis
- Disability affecting the immune response (e.g. Down's syndrome)
Other
- Eczema Area and Severity Index \< 2
- Participation in another intervention or follow-up study
Who the study is looking for
- Eczema Area and Severity Index ≥ 2
Age in the registry: 2 years to 5 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Natural Resources Institute Finland Coordinator of this site? Confirm its status | Helsinki | Finland | Recruiting |
| Tampere University Coordinator of this site? Confirm its status | Tampere | Finland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.